Harry L A Janssen

4PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMedical biochemistry - lipidsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 09, 2025
Effectiveness and tolerability of bezafibrate in primary biliary cholangitis - a nationwide real-world study.

Maria C van Hooff, Rozanne C de Veer, Ellen Werner

|Dec 03, 2025
Tenofovir alafenamide for prevention of HBV reactivation in HBsAg-negative, anti-HBc-positive patients undergoing rituximab-based chemotherapy: A multicenter randomized controlled trial.

Sanam Tabataba Vakili, Grishma Hirode, Atif Zahoor

|Jul 23, 2025
A Comparison of the Predictive Value of 12 Body Composition Markers for Metabolic Dysfunction-Associated Steatotic Liver Disease, At-Risk Metabolic Dysfunction-Associated Steatohepatitis, and Increased Liver Stiffness in a General Population Setting.

Laurens A van Kleef, Maurice Michel, Mesut Savas

|Jun 11, 2024
Reply: The exact predictive value of HBcrAg and HBV RNA in serological status and disease activity in CHB.

Marc G Ghany, Wendy C King, Amanda S Hinerman

Pageof 1

Frequent Collaborators

1 joint publications

Marc G Ghany

1 joint publications

Wendy C King

1 joint publications

Amanda S Hinerman

1 joint publications

Anna S F Lok